ABEO Abeona Therapeutics Inc

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.

$2.36
As of 03/02/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
09/19/1980
98,527,723
7,780,812
$230,554,872
0.00%
SEC Edgar Online
10-Q
10-K
00289Y107
US00289Y1073
BYNS0T7

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-31.86
1.72
32.94
-73.70%
-1,211.96%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy